Insight Advisors, LLC Infinity Pharmaceuticals, Inc. Transaction History

Insight Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.49 - $1.2 $4,900 - $12,000	-10,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.85 - $2.4 $420 - $1,188	-495 Reduced 4.72%	10,000 $11,000
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $35,461 - $89,120	-23,330 Reduced 68.97%	10,495 $28,000
Q2 2021 Aug 12, 2021	SELL	$2.66 - $3.47 $60,581 - $79,029	-22,775 Reduced 40.24%	33,825 $99,000
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $112,068 - $303,376	56,600 New	56,600 $188,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Advisors, LLC with notifications on news.